Sponsor:
Janssen Research & Development, LLC
Code:
NCT05963074
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
Small Lymphocytic Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ibrutinib
Venetoclax
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations